The goal of this prospective cohort is to identified specific biological patterns in patients with a bleeding of unknown cause and to study the specific mechanisms of the bleeding disorder for each subset of patients.
Patients with bleeding of unknown cause are included. At baseline, blood will be drawn to evaluate the hemostatic profile. Findings are compared to a control group of healthy individuals. Patients and controls are followed for 3 years.
Study Type
OBSERVATIONAL
Enrollment
400
Measurement of thrombin generation by ST Genesia
Measurement of fibrinolysis by Lysis Timer
Measurement of fibrin polymerisation and permeability
Ospedale Regionale di Bellinzona
Bellinzona, Switzerland
RECRUITINGInselspital - Universitätsspital Bern
Bern, Switzerland
RECRUITINGUniversity Hospital
Geneva, Switzerland
Fibrin clot polymerisation
maximal absorption (optical density)
Time frame: At inclusion
Fibrin clot permeability
darcy coefficient (ks, cm2)
Time frame: At inclusion
Fibrinolysis
Clot lysis time (min)
Time frame: At inclusion
Thrombin generation
Endogenous thrombin potential (ETP, nM x min)
Time frame: At inclusion
Coated platelets
Absolute number of coated platelets
Time frame: At inclusion
Fibrinogen gamma' levels
Ratio fibrinogen gamma'/total fibrinogen (%)
Time frame: At inclusion
Scan electron microscopy
Fibrin fiber diameter (nm)
Time frame: At inclusion
Clot retraction
Ratio clot weight/serum extruded (%)
Time frame: At inclusion
Plasmin generation
Plasmin (nM)
Time frame: At inclusion
Fibrin clot formation (thrombodynamics)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Measurement of coated platelets by flow cytometry
Centre Hospitalier Universitaire Vaudois
Lausanne, Switzerland
RECRUITINGGruppo Ospedaliero Moncucco
Lugano, Switzerland
RECRUITINGKantonsspital St.Gallen
Sankt Gallen, Switzerland
RECRUITINGUSZ - Universitätsspital Zürich
Zurich, Switzerland
RECRUITINGInitial rate of clot growth (μM/min)
Time frame: At inclusion
Major bleeding episodes
Incidence of major bleeding
Time frame: Three years
Non-major bleeding episodes
Incidence of clinically relevant non-major bleeding
Time frame: Three years
Health related quality of life
SF36 questionnaire, 0 - 100 (high score, better outcome)
Time frame: three years
International Society Thrombosis Hemostasis Bleeding assessment tool
ISTH BAT score, 0 - 56 (high score, worse outcome)
Time frame: three years